BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20586972)

  • 1. A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea.
    Kang EJ; Ko SK
    Value Health; 2009; 12 Suppl 3():S114-7. PubMed ID: 20586972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
    Park SJ; Ahn S; Woo SJ; Park KH
    JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preference-Based EQ-5D index scores for chronic conditions in the United States.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):410-20. PubMed ID: 16855129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Visual Impairment and Chronic Diseases.
    Park SJ; Ahn S; Park KH
    JAMA Ophthalmol; 2016 Jul; 134(7):778-84. PubMed ID: 27196876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea - a comparison with the general population preference weights.
    Hong J
    Health Qual Life Outcomes; 2018 Aug; 16(1):159. PubMed ID: 30075726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in adults with metabolic syndrome: the Korea national health and nutrition examination survey, 2007-2008.
    Lee YJ; Woo SY; Ahn JH; Cho S; Kim SR
    Ann Nutr Metab; 2012; 61(4):275-80. PubMed ID: 23208156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The decline of health-related quality of life associated with some diseases in Korean adults].
    Kil SR; Lee SI; Yun SC; An HM; Jo MW
    J Prev Med Public Health; 2008 Nov; 41(6):434-41. PubMed ID: 19037174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population norms for the EQ-5D index scores using Singapore preference weights.
    Abdin E; Subramaniam M; Vaingankar JA; Luo N; Chong SA
    Qual Life Res; 2015 Jun; 24(6):1545-53. PubMed ID: 25394893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of chronic diseases on health related quality of life in middle-aged and elderly people from rural communities: application of EQ-5D scale on a Health Survey in Fangshan, Beijing].
    Cao Y; Tang X; Yang L; Li N; Wu YQ; Fan WY; Liu JJ; Yu LP; Xu HT; Liu WJ; Wen SS; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jan; 33(1):17-22. PubMed ID: 22575103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of moderate renal dysfunction with impaired preference-based health-related quality of life: third Korean national health and nutritional examination survey.
    Lee H; Oh YJ; Kim M; Kim H; Lee JP; Kim S; Oh KH; Jun Chin H; Joo KW; Lim CS; Kim S; Kim YS; Kim DK
    BMC Nephrol; 2012 Apr; 13():19. PubMed ID: 22530944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses.
    Franks P; Hanmer J; Fryback DG
    Med Care; 2006 May; 44(5):478-85. PubMed ID: 16641667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
    Jia H; Lubetkin EI
    Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
    Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea.
    Jo MW; Yun SC; Lee SI
    Value Health; 2008 Dec; 11(7):1186-9. PubMed ID: 18489498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.